Sarcoma Treatment

Advanced Cancer Treatment at CMN Hospital

Sarcoma is a rare group of cancers that begins in the body’s connective tissues, including bone, muscle, fat, blood vessels, nerves, cartilage, and soft tissue. Sarcomas can develop almost anywhere in the body and may behave very differently depending on the specific subtype, grade, location, and stage.

At CMN Hospital, sarcoma cases are reviewed individually based on diagnosis, pathology, tumor grade, imaging studies, prior treatments, current health status, and overall medical condition.

Types of Sarcoma

Sarcomas are generally grouped into two main categories: soft tissue sarcomas and bone sarcomas. Because there are many subtypes, accurate pathology and imaging review are important before treatment options are discussed.

Soft Tissue Sarcoma

Soft tissue sarcomas may develop in muscle, fat, nerves, blood vessels, or other connective tissues.

Bone Sarcoma

Bone sarcomas begin in the bone and may include osteosarcoma, chondrosarcoma, and Ewing sarcoma.

Common sarcoma types may include:

  • Liposarcoma
  • Leiomyosarcoma
  • Undifferentiated Pleomorphic Sarcoma
  • Synovial Sarcoma
  • Angiosarcoma
  • Malignant Peripheral Nerve Sheath Tumor
  • Rhabdomyosarcoma
  • Gastrointestinal Stromal Tumor
  • Dermatofibrosarcoma Protuberans
  • Osteosarcoma
  • Chondrosarcoma
  • Ewing Sarcoma
  • Recurrent or Metastatic Sarcoma

Signs and Symptoms

Sarcoma symptoms depend on where the tumor develops. Some sarcomas cause a noticeable lump or swelling, while others may not cause symptoms until they grow large enough to press on nearby organs, nerves, muscles, or blood vessels.

  • A growing lump or mass
  • Swelling in an arm, leg, abdomen, or other area
  • Pain or tenderness near the tumor
  • Bone pain or unexplained fracture
  • Abdominal fullness or discomfort
  • Numbness, weakness, or pressure symptoms
  • Unexplained weight loss or fatigue
  • Limited movement when the tumor affects a limb or joint

How Sarcoma Is Diagnosed

Diagnosing sarcoma usually requires imaging and tissue confirmation. Because sarcomas are rare and can be complex, pathology review is especially important.

  • Physical examination and medical history
  • MRI, CT scan, PET scan, or other imaging studies
  • Biopsy of the tumor
  • Pathology review to confirm subtype and grade
  • Molecular or genetic testing when indicated
  • Evaluation for local, regional, or distant spread
  • Review of prior surgery, radiation, chemotherapy, or targeted therapy history

Conventional Treatment Options

Sarcoma treatment depends on the subtype, location, size, grade, stage, prior treatment history, and the patient’s overall health.

  • Surgery when appropriate
  • Radiation therapy
  • Chemotherapy for selected sarcoma types
  • Targeted therapy for certain tumor profiles
  • Immunotherapy in selected cases
  • Limb-sparing approaches when possible
  • Clinical trials when appropriate
  • Supportive care and symptom management

Advanced, Recurrent, or Metastatic Sarcoma

Many patients who contact CMN Hospital have already received surgery, chemotherapy, radiation therapy, targeted therapy, or other treatments before seeking additional options. Others may be facing recurrent, advanced, unresectable, or metastatic sarcoma.

Because sarcoma includes many different diseases, treatment recommendations cannot be based on the word “sarcoma” alone. Dr. Edgar Payán carefully reviews each patient’s pathology reports, imaging studies, tumor location, prior treatments, current condition, and overall health before discussing whether CMN Hospital’s 28-day inpatient Advanced Cancer Treatment program may be appropriate.

Individualized Physician Review

At CMN Hospital, every patient is evaluated individually. Dr. Edgar Payán, General Hospital Director and Medical Director of CMN Hospital, personally reviews each patient’s pathology reports, biopsy results, imaging studies, molecular or genetic testing when available, previous treatments, current health status, and other relevant medical records.

Following this comprehensive review, Dr. Payán meets personally with each patient during a consultation to discuss the findings, answer questions, determine whether CMN Hospital’s 28-day inpatient Advanced Cancer Treatment program may be appropriate, and explain the treatment options available based on the patient’s individual medical evaluation.

If a patient proceeds with treatment, Dr. Payán oversees their care throughout their inpatient stay and continues to personally monitor their progress through scheduled monthly Zoom follow-up appointments after discharge.